Skip to main content
SpringerLink
Log in

Cadherins in Cancer

  • Chapter
Cell Adhesion

Part of the book series: Handbook of Experimental Pharmacology ((HEP,volume 165))

Abstract

The presence of a functional E-cadherin/catenin cell-cell adhesion complex is a prerequisite for normal development and maintenance of epithelial structures in the mammalian body. This implies that the acquisition of molecular abnormalities that disturb the expression or function of this complex is related to the development and progression of most, if not all, epithelial cell-derived tumors, i.e. carcinomas. E-cadherin downregulation is indeed correlated with malignancy parameters such as tumor progression, loss of differentiation, invasion and metastasis, and hence poor prognosis. Moreover, E-cadherin has been shown to be a potent invasion suppressor as well as a tumor suppressor. Disturbed expression profiles of the E-cadherin/catenin complex have been demonstrated in histological sections of many human tumor types. In different kinds of carcinomas, biallelic downregulation of the E-cadherin gene, resulting in tumor-restricted decrease or even complete loss of E-cadherin expression, appears to be caused by a variety of inactivation mechanisms. Gene deletion due to loss of heterozygosity of the CDH1 locus on 16q22.1 frequently occurs in many carcinoma types. However, somatic inactivating mutations resulting in aberrant E-cadherin expression by loss of both wild-type alleles is rare and restricted to only a few cancer types. A majority of carcinomas thus seems to show deregulated E-cadherin expression by other mechanisms. The present evidence proposes transcriptional repression as a powerful and recurrent molecular mechanism for silencing E-cadherin expression. The predominant mechanisms emerging in most carcinomas are hypermethylation of the E-cadherin promoter and expression of transrepressor molecules such as SIP1, Snail, and Slug that bind sequence elements in the proximal E-cadherin promoter. Interestingly, complex differential expression of other cadherins seems to be associated with loss of E-cadherin and to reinforce effects of this loss on tumor progression. Multiple agents can upregulate and stabilize the E-cadherin/catenin complex. Especially for those tumors with transcriptional and thus reversible downregulation of E-cadherin expression, these drug agents offer important therapeutic opportunities.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 259.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 329.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 329.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Acs G, Lawton TJ, Rebbeck TR, Li Volsi VA, Zhang PJ (2001) Differential expression of E-cadherin in lobular and ductal neoplasms of the breast and its biologic and diagnostic implications. Am J Clin Pathol 115:85–98

    Article  CAS  PubMed  Google Scholar 

  • Akimoto T, Mitsuhashi N, Saito Y, Ebara T, Niibe H (1998) Effect of radiation on the expression of E-cadherin and alpha-catenin and invasive capacity in human lung cancer cell line in vitro. Int J Radiat Oncol Biol Phys 41:1171–1176

    CAS  PubMed  Google Scholar 

  • Alpaugh ML, Tomlinson JS, Kasraeian S, Barsky SH (2002a) Cooperative role of E-cadherin and sialyl-Lewis X/A-deficient MUC1 in the passive dissemination of tumor emboli in inflammatory breast carcinoma. Oncogene 21:3631–3643

    Article  CAS  PubMed  Google Scholar 

  • Alpaugh ML, Tomlinson JS, Ye Y, Barsky SH (2002b) Relationship of sialyl-Lewis(x/a) underexpression and E-cadherin overexpression in the lymphovascular embolus of inflammatory breast carcinoma. Am J Pathol 161:619–628

    CAS  PubMed  Google Scholar 

  • Aoki S, Shimamura T, Shibata T, Nakanishi Y, Moriya Y, Sato Y, Kitajima M, Sakamoto M, Hirohashi S (2003) Prognostic significance of dysadherin expression in advanced colorectal carcinoma. Br J Cancer 88:726–732

    Article  CAS  PubMed  Google Scholar 

  • Asgeirsson KS, Olafsdottir K, Jonasson JG, Ogmundsdottir HM (1998) The effects of IL-6 on cell adhesion and E-cadherin expression in breast cancer. Cytokine 10:720–728

    Article  CAS  PubMed  Google Scholar 

  • Ashida K, Terada T, Kitamura Y, Kaibara N (1998) Expression of E-cadherin, alpha-catenin, beta-catenin, and CD44 (standard and variant isoforms) in human cholangiocarcinoma: an immunohistochemical study. Hepatology 27:974–982

    Article  CAS  PubMed  Google Scholar 

  • Auersperg N, Pan J, Grove BD, Peterson T, Fisher J, MainesBandiera S, Somasiri A, Roskelley CD (1999) E-cadherin induces mesenchymal-to-epithelial transition in human ovarian surface epithelium. Proc Natl Acad Sci USA 96:6249–6254

    Article  CAS  PubMed  Google Scholar 

  • Bailey T, Biddlestone L, Shepherd N, Barr H, Warner P, Jankowski J (1998) Altered cadherin and catenin complexes in the Barretts esophagus-dysplasia-adenocarcinoma sequence: correlation with disease progression and dedifferentiation. Am J Pathol 152:135–144

    CAS  PubMed  Google Scholar 

  • Bani D, Flagiello D, Poupon MF, Nistri S, Poirson-Bichat F, Bigazzi M, Bani Sacchi T (1999) Relaxin promotes differentiation of human breast cancer cells MCF-7 transplanted into nude mice. Virchows Arch 435:509–519

    Article  CAS  PubMed  Google Scholar 

  • Batlle E, Sancho E, Franci C, Dominguez D, Monfar M, Baulida J, de Herreros AG (2000) The transcription factor Snail is a repressor of E-cadherin gene expression in epithelial tumour cells. Nat Cell Biol 2:84–89

    Article  CAS  PubMed  Google Scholar 

  • Batsche E, Muchardt C, Behrens J, Hurst HC, Cremisi C (1998) RB and c-Myc activate expression of the E-cadherin gene in epithelial cells through interaction with transcription factor AP-2. Mol Cell Biol 18:1–12

    Google Scholar 

  • Becker I, Becker KF, Röhrl MH, Minkus G, Schütze K, Höfler H (1996) Single-cell mutation analysis of tumors from stained histologic slides. Lab Invest 75:801–807

    CAS  PubMed  Google Scholar 

  • Becker KF, Atkinson MJ, Reich U, Becker I, Nekarda H, Siewert JR, Höfler H (1994) E-cadherin gene mutations provide clues to diffuse type gastric carcinomas. Cancer Res 54:3845–3852

    CAS  PubMed  Google Scholar 

  • Behrens J, Löwrick O, Klein-Hitpass L, Birchmeier W (1991) The E-cadherin promoter: functional analysis of a G.C-rich region and an epithelial cell-specific palindromic regulatory element. Proc Natl Acad Sci USA 88:11495–11499

    Article  CAS  PubMed  Google Scholar 

  • Behrens J, Vakaet L, Friis R, Winterhager E, van Roy F, Mareel MM, Birchmeier W (1993) Loss of epithelial differentiation and gain of invasiveness correlates with tyrosine phosphorylation of the E-cadherin/β-catenin complex in cells transformed with a temperature-sensitive v-src gene. J Cell Biol 120:757–766

    Article  CAS  PubMed  Google Scholar 

  • Berx G, Cleton-Jansen A-M, Nollet F, de Leeuw WJF, van de Vijver MJ, Cornelisse C, van Roy F (1995a) E-cadherin is a tumor/invasion suppressor gene mutated in human lobular breast cancers. EMBO J 14:6107–6115

    CAS  PubMed  Google Scholar 

  • Berx G, Staes K, van Hengel J, Molemans F, Bussemakers MJG, van Bokhoven A, van Roy F (1995b) Cloning and characterization of the human invasion suppressor gene E-cadherin (CDH1). Genomics 26:281–289

    Article  CAS  PubMed  Google Scholar 

  • Berx G, Cleton-Jansen A-M, Strumane K, de Leeuw WJF, Nollet F, van Roy FM, Cornelisse C (1996) E-cadherin is inactivated in a majority of invasive human lobular breast cancers by truncation mutations throughout its extracellular domain. Oncogene 13:1919–1925

    CAS  PubMed  Google Scholar 

  • Berx G, Becker K-F, Höfler H, van Roy F (1998) Mutation update: mutations of the human E-cadherin (CDH1) gene. Hum Mutat 12:226–237

    Article  CAS  PubMed  Google Scholar 

  • Birchmeier C, Birchmeier W, Brand-Saberi B (1996) Epithelial-mesenchymal transitions in cancer progression. Acta Anat 156:217–226

    Article  CAS  PubMed  Google Scholar 

  • Blanco MJ, Moreno-Bueno G, Sarrio D, Locascio A, Cano A, Palacios J, Nieto MA (2002) Correlation of Snail expression with histological grade and lymph node status in breast carcinomas. Oncogene 21:3241–3246

    Article  CAS  PubMed  Google Scholar 

  • Blaschke S, Mueller CA, Markovic-Lipkovski J, Puch S, Miosge N, Becker V, Mueller GA, Klein G (2002) Expression of cadherin-8 in renal cell carcinoma and fetal kidney. Int J Cancer 101:327–334

    Article  CAS  PubMed  Google Scholar 

  • Boggon TJ, Murray J, Chappuis-Flament S, Wong E, Gumbiner BM, Shapiro L (2002) C-cadherin ectodomain structure and implications for cell adhesion mechanisms. Science 296:1308–1313

    Article  CAS  PubMed  Google Scholar 

  • Bolos V, Peinado H, Perez-Moreno MA, Fraga MF, Esteller M, Cano A (2003) The transcription factor Slug represses E-cadherin expression and induces epithelial to mesenchymal transitions: a comparison with Snail and E47 repressors. J Cell Sci 116:499–511

    Article  CAS  PubMed  Google Scholar 

  • Bornman DM, Mathew S, Alsruhe J, Herman JG, Gabrielson E (2001) Methylation of the E-cadherin gene in bladder neoplasia and in normal urothelial epithelium from elderly individuals. Am J Pathol 159:831–835

    CAS  PubMed  Google Scholar 

  • Boterberg T, Vennekens KM, Thienpont M, Mareel MM, Bracke ME (2000) Internalization of the E-cadherin/catenin complex and scattering of human mammary carcinoma cells: MCF-7/AZ after treatment with conditioned medium from human skin squamous carcinoma cells COLO 16. Cell Adhes Commun 7:299–310

    Article  CAS  PubMed  Google Scholar 

  • Boussadia O, Kutsch S, Hierholzer A, Delmas V, Kemler R (2002) E-cadherin is a survival factor for the lactating mouse mammary gland. Mech Develop 115:53–62

    Article  CAS  Google Scholar 

  • Brabant G, Hoangvu C, Cetin Y, Dralle H, Scheumann G, Molne J, Hansson G, Jansson S, Ericson LE, Nilsson M (1993) E-cadherin—a differentiation marker in thyroid malignancies. Cancer Res 53:4987–4993

    CAS  PubMed  Google Scholar 

  • Brabant G, Hoangvu C, Behrends J, Cetin Y, Potter E, Dumont JE, Maenhaut C (1995) Regulation of the cell-cell adhesion protein, E-cadherin, in dog and human thyrocytes in vitro. Endocrinology 136:3113–3119

    Article  CAS  PubMed  Google Scholar 

  • Brabletz T, Jung A, Reu S, Porzner M, Hlubek F, KunzSchughart LA, Knuechel R, Kirchner T (2001) Variable beta-catenin expression in colorectal cancers indicates tumor progression driven by the tumor environment. Proc Natl Acad Sci USA 98:10356–10361

    Article  CAS  PubMed  Google Scholar 

  • Bracke ME, Charlier C, Bruyneel EA, Labit C, Mareel MM, Castronovo V (1994) Tamoxifen restores the E-cadherin function in human breast cancer MCF-7/6 cells and suppresses their invasive phenotype. Cancer Res 54:4607–4609

    CAS  PubMed  Google Scholar 

  • Bracke ME, Boterberg T, Depypere HT, Stove C, Leclercq G, Mareel MM (2002) The citrus methoxyflavone tangeretin affects human cell-cell interactions. Advances in Experimental and Medical Biology 505:135–139

    CAS  Google Scholar 

  • Bukholm IK, Nesland JM, Karesen R, Jacobsen U, Borresen-Dale AL (1997) Expression of E-cadherin and its relation to the p53 protein status in human breast carcinomas. Virchows Arch 431:317–321

    Article  CAS  PubMed  Google Scholar 

  • Bukholm IK, Nesland JM, Borresen-Dale AL (2000) Re-expression of E-cadherin, alpha-catenin and beta-catenin, but not of gamma-catenin, in metastatic tissue from breast cancer patients. J Pathol 190:15–19

    Article  CAS  PubMed  Google Scholar 

  • Bussemakers MJG, Giroldi LA, Vanbokhoven A, Schalken JA (1994) Transcriptional regulation of the human E-cadherin gene in human prostate cancer cell lines: characterization of the human E-cadherin gene promoter. Biochem Biophys Res Commun 203:1284–1290

    Article  CAS  PubMed  Google Scholar 

  • Bussemakers MJG, Van Bokhoven A, Tomita K, Jansen CFJ, Schalken JA (2000) Complex cadherin expression in human prostate cancer cells. Int J Cancer 85:446–450

    Article  CAS  PubMed  Google Scholar 

  • Caldas C, Carneiro F, Lynch HT, Yokota J, Wiesner GL, Powell SM, Lewis FR, Huntsman DG, Pharoah PDP, Jankowski JA, MacLeod P, Vogelsang H, Keller G, Park KGM, Richards FM, Maher ER, Gayther SA, Oliveira C, Grehan N, Wight D, Seruca R, Roviello F, Ponder BAJ, Jackson CE (1999) Familial gastric cancer: overview and guidelines for management. J Med Genet 36:873–880

    CAS  PubMed  Google Scholar 

  • Cano A, Perez-Moreno MA, Rodrigo I, Locascio A, Blanco MJ, del Barrio MG, Portillo F, Nieto MA (2000) The transcription factor Snail controls epithelial-mesenchymal transitions by repressing E-cadherin expression. Nat Cell Biol 2:76–83

    Article  CAS  PubMed  Google Scholar 

  • Carico E, Atlante M, Bucci B, Nofroni I, Vecchione A (2001) E-cadherin and alpha-catenin expression during tumor progression of cervical carcinoma. Gynecol Oncol 80:156–161

    Article  CAS  PubMed  Google Scholar 

  • Carruba G, Miceli D, Damico D, Farruggio R, Comito L, Montesanti A, Polito L, Castagnetta LAM (1995) Sex steroids up-regulate E-cadherin expression in hormoneresponsive LNCap human prostate cancer cells. Biochem Biophys Res Commun 212:624–631

    Article  CAS  PubMed  Google Scholar 

  • Carter BS, Ewing CM, Ward WS, Treiger BF, Aalders TW, Schalken JA, Epstein JI, Isaacs WB (1990) Allelic loss of chromosomes 16q and 10q in human prostate cancer. Proc Natl Acad Sci USA 87:8751–8755

    Article  CAS  PubMed  Google Scholar 

  • Chan TA, Wang ZH, Dang LH, Vogelstein B, Kinzler KW (2002) Targeted inactivation of CTNNB1 reveals unexpected effects of beta-catenin mutation. Proc Natl Acad Sci USA 99:8265–8270

    Article  CAS  PubMed  Google Scholar 

  • Chen WC, Obrink B (1991) Cell-cell contacts mediated by E-cadherin (uvomorulin) restrict invasive behavior of L-cells. J Cell Biol 114:319–327

    Article  CAS  PubMed  Google Scholar 

  • Cheng CW, Wu PE, Yu JC, Huang CS, Yue CT, Wu CW, Shen CY (2001) Mechanisms of inactivation of E-cadherin in breast carcinoma: modification of the two-hit hypothesis of tumor suppressor gene. Oncogene 20:3814–3823

    Article  CAS  PubMed  Google Scholar 

  • Chun YS, Lindor NM, Smyrk TC, Petersen BT, Burgart LJ, Guilford PJ, Donohue JH (2001) Germline E-cadherin gene mutations: is prophylactic total gastrectomy indicated? Cancer 92:181–187

    Article  CAS  PubMed  Google Scholar 

  • Cleton-Jansen AM, Callen DF, Seshadri R, Goldup S, McCallum B, Crawford J, Powell JA, Settasatian C, van Beerendonk H, Moerland EW, Smit VT, Harris WH, Millis R, Morgan NV, Barnes D, Mathew CG, Cornelisse CJ (2001) Loss of heterozygosity mapping at chromosome arm 16q in 712 breast tumors reveals factors that influence delineation of candidate regions. Cancer Res 61:1171–1177

    CAS  PubMed  Google Scholar 

  • Colpaert CG, Vermeulen PB, Benoy I, Soubry A, Van Roy F, Van Beest P, Goovaerts G, Dirix LY, Van Dam P, Fox SB, Harris AL, Van Marck EA (2003) Inflammatory breast cancer shows angiogenesis with high endothelial proliferation rate and strong E-cadherin expression. Br J Cancer 88:718–725

    Article  CAS  PubMed  Google Scholar 

  • Comijn J, Berx G, Vermassen P, Verschueren K, van Grunsven L, Bruyneel E, Mareel M, Huylebroeck D, van Roy F (2001) The two-handed E-box-binding zinc finger protein SIP1 downregulates E-cadherin and induces invasion. Mol Cell 7:1267–1278

    Article  CAS  PubMed  Google Scholar 

  • Corn PG, Heath EI, Heitmiller R, Fogt F, Forastiere AA, Herman JG, Wu TT (2001) Frequent hypermethylation of the 5′ CpG island of E-cadherin in esophageal adenocarcinoma. Clin Cancer Res 7:2765–2769

    CAS  PubMed  Google Scholar 

  • D’Souza B, Taylor-Papadimitriou J (1994) Overexpression of erb-B2 in human mammary epithelial cells signals inhibition of transcription of the E-cadherin gene. Proc Natl Acad Sci USA 91:7202–7206

    Article  PubMed  Google Scholar 

  • Dahl U, Sjodin A, Semb H (1996) Cadherins regulate aggregation of pancreatic beta-cells in vivo. Development 122:2895–2902

    CAS  PubMed  Google Scholar 

  • Daniel JM, Reynolds AB (1997) Tyrosine phosphorylation and cadherin/catenin function. Bioessays 19:883–891

    Article  CAS  PubMed  Google Scholar 

  • Davies G, Jiang WG, Mason MD (2001) Matrilysin mediates extracellular cleavage of E-cadherin from prostate cancer cells: a key mechanism in hepatocyte growth factor/scatter factor-induced cell-cell dissociation and in vitro invasion. Clin Cancer Res 7:3289–3297

    CAS  PubMed  Google Scholar 

  • Day ML, Zhao X, Vallorosi CJ, Putzi M, Powell CT, Lin C, Day KC (1999) E-cadherin mediates aggregation-dependent survival of prostate and mammary epithelial cells through the retinoblastoma cell cycle control pathway. J Biol Chem 274:9656–9664

    Article  CAS  PubMed  Google Scholar 

  • de Leeuw WJF, Berx G, Vos CBJ, Peterse JL, van de Vijver MJ, Litvinov S, van Roy FM, Cornelisse CJ, Cleton-Jansen A-M (1997) Simultaneous loss of E-cadherin and catenins in invasive lobular breast cancer and lobular carcinoma in situ. J Pathol 183:404–411

    Article  PubMed  Google Scholar 

  • Debruyne P, Vermeulen S, Mareel M (1999) The role of the E-cadherin/catenin complex in gastrointestinal cancer. Acta Gastroenterol Belg 62:393–402

    CAS  PubMed  Google Scholar 

  • Decary S, Decesse JT, Ogryzko V, Reed JC, Naguibneva I, Harel-Bellan A, Cremisi CE (2002) The retinoblastoma protein binds the promoter of the survival gene bcl-2 and regulates its transcription in epithelial cells through transcription factor AP-2. Mol Cell Biol 22:7877–7888

    Article  CAS  PubMed  Google Scholar 

  • del Muro XG, Torregrosa A, Munoz J, Castellsague X, Condom E, Vigues F, Arance A, Fabra A, Germa JR (2000) Prognostic value of the expression of E-cadherin and betacatenin in bladder cancer. Eur J Cancer 36:357–362

    Article  Google Scholar 

  • Dorudi S, Hanby AM, Poulsom R, Northover J, Hart IR (1995) Level of expression of E-cadherin mRNA in colorectal cancer correlates with clinical outcome. Br J Cancer 71:614–616

    CAS  PubMed  Google Scholar 

  • Droufakou S, Deshmane V, Roylance R, Hanby A, Tomlinson I, Hart IR (2001) Multiple ways of silencing E-cadherin gene expression in lobular carcinoma of the breast. Int J Cancer 92:404–408

    Article  CAS  PubMed  Google Scholar 

  • Eckert K, Fuhrmann-Selter T, Maurer HR (1997) Docetaxel enhances the expression of E-Cadherin and carcinoembryonic antigen (CEA) on human colon cancer cell lines in vitro. Anticancer Res 17:7–12

    CAS  PubMed  Google Scholar 

  • El-Hariry I, Pignatelli M, Lemoine NR (2001a) FGF-1 and FGF-2 modulate the E-cadherin/catenin system in pancreatic adenocarcinoma cell lines. Br J Cancer 84:1656–1663

    Article  CAS  PubMed  Google Scholar 

  • El-Hariry I, Pignatelli M, Lemoine NR (2001b) FGF-1 and FGF-2 regulate the expression of E-cadherin and catenins in pancreatic adenocarcinoma. Int J Cancer 94:652–661

    Article  CAS  PubMed  Google Scholar 

  • Elzagheid A, Kuopio T, Ilmen M, Collan Y (2002) Prognostication of invasive ductal breast cancer by quantification of E-cadherin immunostaining: the methodology and clinical relevance. Histopathol 41:127–133

    Article  CAS  Google Scholar 

  • Feltes CM, Kudo A, Blaschuk O, Byers SW (2002) An alternatively spliced cadherin-11 enhances human breast cancer cell invasion. Cancer Res 62:6688–6697

    CAS  PubMed  Google Scholar 

  • Frixen UH, Behrens J, Sachs M, Eberle G, Voss B, Warda A, Löchner D, Birchmeier W (1991) E-cadherin-mediated cell-cell adhesion prevents invasiveness of human carcinoma cells. J Cell Biol 113:173–185

    Article  CAS  PubMed  Google Scholar 

  • Fujioka S, Kohno N, Hiwada K (1995) Ubenimex activates the E-cadherin-mediated adhesion of a breast cancer cell line YMB-S. Jpn J Cancer Res 86:368–373

    CAS  PubMed  Google Scholar 

  • Fujita N, Jaye DL, Kajita M, Geigerman C, Moreno CS, Wade PA (2003) MTA3, a Mi-2/NuRD complex subunit, regulates an invasive growth pathway in breast cancer. Cell 113:207–219

    Article  CAS  PubMed  Google Scholar 

  • Fujita Y, Krause G, Scheffner M, Zechner D, Leddy HEM, Behrens J, Sommer T, Birchmeier W (2002) Hakai, a c-Cbl-like protein, ubiquitinates and induces endocytosis of the E-cadherin complex. Nat Cell Biol 4:222–231

    Article  CAS  PubMed  Google Scholar 

  • Gamallo C, Moreno-Bueno G, Sarrio D, Calero F, Hardisson D, Palacios J (2001) The prognostic significance of P-cadherin in infiltrating ductal breast carcinoma. Modern Pathol 14:650–654

    Article  CAS  Google Scholar 

  • Gayther SA, Gorringe KL, Ramus SJ, Huntsman D, Roviello F, Grehan N, Machado JE, Pinto E (1998) Identification of germ-line E-cadherin mutations in gastric cancer families of European origin. Cancer Res 58:4086–4089

    CAS  PubMed  Google Scholar 

  • Ghadimi BM, Behrens J, Hoffmann I, Haensch W, Birchmeier W, Schlag PM (1999) Immunohistological analysis of E-cadherin, alpha-, beta-and gamma-catenin expression in colorectal cancer: implications for cell adhesion and signaling. Eur J Cancer 35:60–65

    Article  CAS  PubMed  Google Scholar 

  • Giroldi LA, Bringuier PP, de Weijert M, Jansen C, van Bokhoven A, Schalken JA (1997) Role of E boxes in the repression of E-cadherin expression. Biochem Biophys Res Commun 241:453–458

    Article  CAS  PubMed  Google Scholar 

  • Goossens K, Deboel L, Swinnen JV, Roskams T, Manin M, Rombauts W, Verhoeven G (2002) Both retinoids and androgens are required to maintain or promote functional differentiation in reaggregation cultures of human prostate epithelial cells. Prostate 53:34–49

    Article  CAS  PubMed  Google Scholar 

  • Gotzmann J, Huber H, Thallinger C, Wolschek M, Jansen B, Schulte-Hermann R, Beug H, Mikulits W (2002) Hepatocytes convert to a fibroblastoid phenotype through the cooperation of TGF-beta1 and Ha-Ras: steps towards invasiveness. J Cell Sci 115:1189–1202

    CAS  PubMed  Google Scholar 

  • Grady WM, Willis J, Guilford PJ, Dunbier AK, Toro TT, Lynch H, Wiesner G, Ferguson K, Eng C, Park JG, Kim SJ, Markowitz S (2000) Methylation of the CDH1 promoter as the second genetic hit in hereditary diffuse gastric cancer. Nat Genet 26:16–17

    Article  CAS  PubMed  Google Scholar 

  • Graff JR, Herman JG, Lapidus RG, Chopra H, Xu R, Jarrard DF, Isaacs WB, Pitha PM, Davidson NE, Baylin SB (1995) E-cadherin expression is silenced by DNA hypermethylation in human breast and prostate carcinomas. Cancer Res 55:5195–5199

    CAS  PubMed  Google Scholar 

  • Graff JR, Gabrielson E, Fujii H, Baylin SB, Herman JG (2000) Methylation patterns of the E-cadherin 5′ CpG island are unstable and reflect the dynamic, heterogeneous loss of E-cadherin expression during metastatic progression. J Biol Chem 275:2727–2732

    Article  CAS  PubMed  Google Scholar 

  • Grille SJ, Bellacosa A, Upson J, Klein-Szanto AJ, Van Roy F, Lee-Kwon W, Donowitz M, Tsichlis PN, Larue L (2003) The protein kinase Akt induces epithelial mesenchymal transition and promotes enhanced motility and invasiveness of squamous cell carcinoma lines. Cancer Res 63:2172–2178

    CAS  PubMed  Google Scholar 

  • Grooteclaes M, Deveraux Q, Hildebrand J, Zhang Q, Goodman RH, Frisch SM (2003) C-terminal-binding protein corepresses epithelial and proapoptotic gene expression programs. Proc Natl Acad Sci USA 100:4568–4573

    Article  CAS  PubMed  Google Scholar 

  • Grooteclaes ML, Frisch SM (2000) Evidence for a function of CtBP in epithelial gene regulation and anoikis. Oncogene 19:3823–3828

    Article  CAS  PubMed  Google Scholar 

  • Guilford P, Hopkins J, Harraway J, McLeod M, McLeod N, Harawira P, Taite H, Scoular R, Miller A, Reeve AE (1998) E-cadherin germline mutations in familial gastric cancer. Nature 392:402–405

    Article  CAS  PubMed  Google Scholar 

  • Guilford PJ, Hopkins JBW, Grady WM, Markowitz SD, Willis J, Lynch H, Rajput A, Wiesner GL, Lindor NM, Burgart LJ, Toro TT, Lee D, Limacher JM, Shaw DW, Findlay MPN, Reeve AE (1999) E-cadherin germline mutations define an inherited cancer syndrome dominated by diffuse gastric cancer. Hum Mutat 14:249–255

    Article  CAS  PubMed  Google Scholar 

  • Gunji N, Oda T, Todoroki T, Kanazawa N, Kawamoto T, Yuzawa K, Scarpa A, Fukao K (1998) Pancreatic carcinoma—correlation between E-cadherin and alpha-catenin expression status and liver metastasis. Cancer 82:1649–1656

    Article  CAS  PubMed  Google Scholar 

  • Guriec N, Marcellin L, Gairard B, Calderoli H, Wilk A, Renaud R, Bergerat JP, Oberling F (1996) E-cadherin mRNA expression in breast carcinomas correlates with overall and disease-free survival. Invas Metast 16:19–26

    CAS  Google Scholar 

  • Guvakova MA, Surmacz E (1997) Overexpressed IGF-I receptors reduce estrogen growth requirements, enhance survival, and promote E-cadherin-mediated cell-cell adhesion in human breast cancer cells. Exp Cell Res 231:149–162

    Article  CAS  PubMed  Google Scholar 

  • Hajra KM, Ji XD, Fearon ER (1999) Extinction of E-cadherin expression in breast cancer via a dominant repression pathway acting on proximal promoter elements. Oncogene 18:7274–7279

    Article  CAS  PubMed  Google Scholar 

  • Hajra KM, Chen DY, Fearon ER (2002) The SLUG zinc-finger protein represses E-cadherin in breast cancer. Cancer Res 62:1613–1618

    CAS  PubMed  Google Scholar 

  • Handschuh G, Candidus S, Luber B, Reich U, Schott C, Oswald S, Becke H, Hutzler P, Birchmeier W, Hofler H, Becker KF (1999) Tumour-associated E-cadherin mutations alter cellular morphology, decrease cellular adhesion and increase cellular motility. Oncogene 18:4301–4312

    Article  CAS  PubMed  Google Scholar 

  • Handschuh G, Luber B, Hutzler P, Hofler H, Becker KF (2001) Single amino acid substitutions in conserved extracellular domains of E-cadherin differ in their functional consequences. J Mol Biol 314:445–454

    Article  CAS  PubMed  Google Scholar 

  • Hao XP, Palazzo JP, Ilyas M, Tomlinson I, Talbot IC (1997) Reduced expression of molecules of the cadherin/catenin complex in the transition from colorectal adenoma to carcinoma. Anticancer Res 17:2241–2247

    CAS  PubMed  Google Scholar 

  • Hazan RB, Kang L, Whooley BP, Borgen PI (1997) N-cadherin promotes adhesion between invasive breast cancer cells and the stroma. Cell Adhes Commun 4:399–411

    Article  CAS  PubMed  Google Scholar 

  • Hazan RB, Phillips GR, Qiao RF, Norton L, Aaronson SA (2000) Exogenous expression of N-cadherin in breast cancer cells induces cell migration, invasion, and metastasis. J Cell Biol 148:779–790

    Article  CAS  PubMed  Google Scholar 

  • Hemavathy K, Guru SC, Harris J, Chen JD, Ip YT (2000) Human slug is a repressor that localizes to sites of active transcription. Mol Cell Biol 20:5087–5095

    Article  CAS  PubMed  Google Scholar 

  • Hennig G, Behrens J, Truss M, Frisch S, Reichmann E, Birchmeier W (1995) Progression of carcinoma cells is associated with alterations in chromatin structure and factor binding at the E-cadherin promoter in vivo. Oncogene 11:475–484

    CAS  PubMed  Google Scholar 

  • Hennig G, Lowrick O, Birchmeier W, Behrens J (1996) Mechanisms identified in the transcriptional control of epithelial gene expression. J Biol Chem 271:595–602

    Article  CAS  PubMed  Google Scholar 

  • Herlyn M, Berking C, Li G, Satyamoorthy K (2000) Lessons from melanocyte development for understanding the biological events in naevus and melanoma formation. Melanoma Res 10:303–312

    Article  CAS  PubMed  Google Scholar 

  • Hirohashi S (1998) Inactivation of the E-cadherin-mediated cell adhesion system in human cancers. Am J Pathol 153:333–339

    CAS  PubMed  Google Scholar 

  • Hiscox S, Jiang WG (1997) Interleukin-12, an emerging anti-tumour cytokine. In Vivo 11:125–132

    CAS  PubMed  Google Scholar 

  • Hosono S, Gross I, English MA, Hajra KM, Fearon ER, Licht JD (2000) E-cadherin is a WT1 target gene. J Biol Chem 275:10943–10953

    Article  CAS  PubMed  Google Scholar 

  • Hsu MY, Meier FE, Nesbit M, Hsu JY, VanBelle P, Elder DE, Herlyn M (2000) E-cadherin expression in melanoma cells restores keratinocyte-mediated growth control and down-regulates expression of invasion-related adhesion receptors. Am J Pathol 156:1515–1525

    CAS  PubMed  Google Scholar 

  • Hu PQ, EJ OK, Rubenstein DS (2001) Tyrosine phosphorylation of human keratinocyte beta-catenin and plakoglobin reversibly regulates their binding to E-cadherin and alpha-catenin. J Invest Dermatol 117:1059–1067

    Article  CAS  PubMed  Google Scholar 

  • Hu XC, Loo WTY, Chow LWC (2002) E-cadherin promoter methylation can regulate its expression in invasive ductal breast cancer tissue in Chinese woman. Life Sci 71:1397–1404

    Article  CAS  PubMed  Google Scholar 

  • Huang ZY, Wu YL, Hedrick N, Gutmann DH (2003) T-cadherin-mediated cell growth regulation involves G(2) phase arrest and requires p21 (CIP1/WAF1) expression. Mol Cell Biol 23:566–578

    Article  CAS  PubMed  Google Scholar 

  • Humar B, Toro T, Graziano F, Muller H, Dobbie Z, KwangYang H, Eng C, Hampel H, Gilbert D, Winship I, Parry S, Ward R, Findlay M, Christian A, Tucker M, Tucker K, Merriman T, Guilford P (2002) Novel germline CDH1 mutations in hereditary diffuse gastric cancer families. Hum Mutat 19:518–525

    Article  CAS  PubMed  Google Scholar 

  • Ihara A, Koizumi H, Hashizume R, Uchikoshi T (1996) Expression of epithelial cadherin and alpha-and beta-catenins in nontumoral livers and hepatocellular carcinomas. Hepatology 23:1441–1447

    CAS  PubMed  Google Scholar 

  • Ikonen T, Matikainen M, Mononen N, Hyytinen ER, Helin HJ, Tommola S, Tammela TL, Pukkala E, Schleutker J, Kallioniemi OP, Koivisto PA (2001) Association of E-cadherin germ-line alterations with prostate cancer. Clin Cancer Res 7:3465–3471

    CAS  PubMed  Google Scholar 

  • Ino Y, Gotoh M, Sakamoto M, Tsukagoshi K, Hirohashi S (2002) Dysadherin, a cancer-associated cell membrane glycoprotein, down-regulates E-cadherin and promotes metastasis. Proc Natl Acad Sci USA 99:365–370

    Article  CAS  PubMed  Google Scholar 

  • Ji XD, Woodard AS, Rimm DL, Fearon ER (1997) Transcriptional defects underlie loss of E-cadherin expression in breast cancer. Cell Growth Differ 8:773–778

    CAS  PubMed  Google Scholar 

  • Jiang MC, Liao CF, Lee PH (2001) Aspirin inhibits matrix metalloproteinase-2 activity, increases E-cadherin production, and inhibits in vitro invasion of tumor cells. Biochem Biophys Res Commun 282:671–677

    Article  CAS  PubMed  Google Scholar 

  • Jiao W, Miyazaki K, Kitajima Y (2002) Inverse correlation between E-cadherin and Snail expression in hepatocellular carcinoma cell lines in vitro and in vivo. Br J Cancer 86:98–101

    Article  CAS  PubMed  Google Scholar 

  • Jonsson BA, Bergh A, Stattin P, Emmanuelsson M, Gronberg H (2002) Germline mutations in E-cadherin do not explain association of hereditary prostate cancer, gastric cancer and breast cancer. Int J Cancer 98:838–843

    Article  CAS  PubMed  Google Scholar 

  • Kanai Y, Ushijima S, Hui AM, Ochiai A, Tsuda H, Sakamoto M, Hirohashi S (1997) The E-cadherin gene is silenced by CpG methylation in human hepatocellular carcinomas. Int J Cancer 71:355–359

    Article  CAS  PubMed  Google Scholar 

  • Kanai Y, Ushijima S, Tsuda H, Sakamoto M, Hirohashi S (2000) Aberrant DNA methylation precedes loss of heterozygosity on chromosome 16 in chronic hepatitis and liver cirrhosis. Cancer Lett 148:73–80

    Article  CAS  PubMed  Google Scholar 

  • Kanazawa T, Watanabe T, Kazama S, Tada T, Koketsu S, Nagawa H (2002) Poorly differentiated adenocarcinoma and mucinous carcinoma of the colon and rectum show higher rates of loss of heterozygosity and loss of E-cadherin expression due to methylation of promoter region. Int J Cancer 102:225–229

    Article  CAS  PubMed  Google Scholar 

  • Karube H, Masuda H, Ishii Y, Takayama T (2002) E-cadherin expression is inversely proportional to tumor size in experimental liver metastases. J Surg Res 106:173–178

    Article  CAS  PubMed  Google Scholar 

  • Kashima T, Kawaguchi J, Takeshita S, Kuroda M, Takanashi M, Horiuchi H, Imamura T, Ishikawa Y, Ishida T, Mori S, Machinami R, Kudo A (1999) Anomalous cadherin expression in osteosarcoma—possible relationships to metastasis and morphogenesis. Am J Pathol 155:1549–1555

    CAS  PubMed  Google Scholar 

  • Kashima T, Nakamura K, Kawaguchi J, Takanashi M, Ishida T, Aburatani H, Kudo A, Fukayama M, Grigoriadis AE (2003) Overexpression of cadherins suppresses pulmonary metastasis of osteosarcoma in vivo. Int J Cancer 104:147–154

    Article  CAS  PubMed  Google Scholar 

  • Kawaguchi J, Takeshita S, Kashima T, Imai T, Machinami R, Kudo A (1999) Expression and function of the splice variant of the human cadherin-11 gene in subordination to intact cadherin-11. J Bone Miner Res 14:764–775

    Article  CAS  PubMed  Google Scholar 

  • Kawakami M, Staub J, Cliby W, Hartmann L, Smith DI, Shridhar V (1999) Involvement of H-cadherin (CDH13) on 16q in the region of frequent deletion in ovarian cancer. Int J Oncol 15:715–720

    CAS  PubMed  Google Scholar 

  • Keller G, Vogelsang H, Becker I, Hutter J, Ott K, Candidus S, Grundei T, Becker KF, Mueller J, Siewert JR, Hofler H (1999) Diffuse type gastric and lobular breast carcinoma in a familial gastric cancer patient with an E-cadherin germline mutation. Am J Pathol 155:337–342

    CAS  PubMed  Google Scholar 

  • Kihana T, Yano N, Murao S, Iketani H, Hamada K, Yano J, Matsuura S (1996) Allelic loss of chromosome 16q in endometrial cancer: Correlation with poor prognosis of patients and less differentiated histology. Jpn J Cancer Res 87:1184–1190

    CAS  PubMed  Google Scholar 

  • Kimura T, Sato H, Manabe R, Konishi H, Kushima R, Sugihara H, Hattori T, Kodama T, Kashima K (1997) Analysis of microsatellite regions and DNA ploidy pattern in signet ring cell carcinomas of the stomach. Gan To Kagaku Ryoho 24:273–278

    PubMed  Google Scholar 

  • Kleer CG, van Golen KL, Braun T, Merajver SD (2001) Persistent E-cadherin expression in inflammatory breast cancer. Modern Pathol 14:458–464

    Article  CAS  Google Scholar 

  • Knudson AG (1971) Mutation and cancer: statistical study of retinoblastoma. Proc Natl Acad Sci USA 68:820–823

    Article  PubMed  Google Scholar 

  • Kondo K, Kohno N, Yokoyama A, Hiwada K (1998) Decreased MUC1 expression induces E-cadherin-mediated cell adhesion of breast cancer cell lines. Cancer Res 58:2014–2019

    CAS  PubMed  Google Scholar 

  • Kufe D, Inghirami G, Abe M, Hayes D, Justi-Wheeler H, Schlom J (1984) Differential reactivity of a novel monoclonal antibody (DF3) with human malignant versus benign breast tumors. Hybridoma 3:223–232

    Article  CAS  PubMed  Google Scholar 

  • Laskin WB, Miettinen M (2002) Epithelial-type and neural-type cadherin expression in malignant noncarcinomatous neoplasms with epithelioid features that involve the soft tissues. Arch Pathol Labor Med 126:425–431

    Google Scholar 

  • Latil A, Cussenot O, Fournier G, Driouch K, Lidereau R (1997) Loss of heterozygosity at chromosome 16q in prostate adenocarcinoma: Identification of three independent regions. Cancer Res 57:1058–1062

    CAS  PubMed  Google Scholar 

  • Lee SW (1996) H-cadherin, a novel cadherin with growth inhibitory functions and diminished expression in human breast cancer. Nat Med 2:776–782

    Article  CAS  PubMed  Google Scholar 

  • Lei HX, Sjoberg-Margolin S, Salahshor S, Werelius B, Jandakova E, Hemminki K, Lindblom A, Vorechovsky I (2002) CDH1 mutations are present in both ductal and lobular breast cancer, but promoter allelic variants show no detectable breast cancer risk. Int J Cancer 98:199–204

    Article  CAS  PubMed  Google Scholar 

  • Leung WK, Yu J, Ng EKW, To KF, Ma PK, Lee TL, Go MYY, Chung SCS, Sung JJY (2001) Concurrent hypermethylation of multiple tumor-related genes in gastric carcinoma and adjacent normal tissues. Cancer 91:2294–2301

    Article  CAS  PubMed  Google Scholar 

  • Lewis FR, Mellinger JD, Hayashi A, Lorelli D, Monaghan KG, Carneiro F, Huntsman DG, Jackson CE, Caldas C (2001) Prophylactic total gastrectomy for familial gastric cancer. Surgery 130:612–617

    Article  CAS  PubMed  Google Scholar 

  • Li CD, Berx G, Larsson C, Auer G, Aspenblad U, Pan Y, Sundelin B, Ekman M, Nordenskjöld M, van Roy F, Bergerheim USR (1999) Distinct deleted regions on chromosome segment 16q23–24 associated with metastases in prostate cancer. Gene Chromos Cancer 24:175–182

    Article  CAS  Google Scholar 

  • Li G, Satyamoorthy K, Herlyn M (2001) N-cadherin-mediated intercellular interactions promote survival and migration of melanoma cells. Cancer Res 61:3819–3825

    CAS  PubMed  Google Scholar 

  • Lochter A, Galosy S, Muschler J, Freedman N, Werb Z, Bissell MJ (1997) Matrix metalloproteinase stromelysin-1 triggers a cascade of molecular alterations that leads to stable epithelial-to-mesenchymal conversion and a premalignant phenotype in mammary epithelial cells. J Cell Biol 139:1861–1872

    Article  CAS  PubMed  Google Scholar 

  • Lowy AM, Knight J, Groden J (2002) Restoration of E-cadherin/beta-catenin expression in pancreatic cancer cells inhibits growth by induction of apoptosis. Surgery 132:141–148

    Article  PubMed  Google Scholar 

  • Luo J, Lubaroff DM, Hendrix MJC (1999) Suppression of prostate cancer invasive potential and matrix metalloproteinase activity by E-cadherin transfection. Cancer Res 59:3552–3556

    CAS  PubMed  Google Scholar 

  • Maccalman CD, Farookhi R, Blaschuk OW (1994) Estradiol regulates E-cadherin mRNA levels in the surface epithelium of the mouse ovary. Clin Exp Metastas 12:276–282

    Article  CAS  Google Scholar 

  • Machado JC, Soares P, Carneiro F, Rocha A, Beck S, Blin N, Berx G, Sobrinho-Simoes M (1999) E-cadherin gene mutations provide a genetic basis for the phenotypic divergence of mixed gastric carcinomas. Lab Invest 79:459–465

    CAS  PubMed  Google Scholar 

  • Makagiansar IT, Avery M, Hu Y, Audus KL, Siahaan TJ (2001) Improving the selectivity of HAV-peptides in modulating E-cadherin-E-cadherin interactions in the intercellular junction of MDCK cell monolayers. Pharmaceut Res 18:446–453

    Article  CAS  Google Scholar 

  • Mansouri A, Spurr N, Goodfellow PN, Kemler R (1988) Characterization and chromosomal localization of the gene encoding the human cell adhesion molecule uvomorulin. Differentiation 38:67–71

    Article  CAS  PubMed  Google Scholar 

  • Marambaud P, Shioi J, Serban G, Georgakopoulos A, Sarner S, Nagy V, Baki L, Wen P, Efthimiopoulos S, Shao Z, Wisniewski T, Robakis NK (2002) A presenilin-1/gammasecretase cleavage releases the E-cadherin intracellular domain and regulates disassembly of adherens junctions. EMBO J 21:1948–1956

    Article  CAS  PubMed  Google Scholar 

  • Mareel M, Bracke M, Van Roy F (1995) Cancer metastasis: negative regulation by an invasion suppressor gene. Cancer Detect Prev 19:451–464

    CAS  PubMed  Google Scholar 

  • Mareel MM, Behrens J, Birchmeier W, De Bruyne GK, Vleminckx K, Hoogewijs A, Fiers WC, van Roy FM (1991) Down-regulation of E-cadherin expression in Madin Darby canine kidney (MDCK) cells inside tumors of nude mice. Int J Cancer 47:922–928

    Article  CAS  PubMed  Google Scholar 

  • Marotta A, Tan C, Gray V, Malik S, Gallinger S, Sanghera J, Dupuis B, Owen D, Dedhar S, Salh B (2001) Dysregulation of integrin-linked kinase (ILK) signaling in colonic polyposis. Oncogene 20:6250–6257

    Article  CAS  PubMed  Google Scholar 

  • Maruyama R, Toyooka S, Toyooka KO, Harada K, Virmani AK, Zochbauer-Muller S, Farinas AJ, Vakar-Lopez F, Minna JD, Sagalowsky A, Czerniak B, Gazdar AF (2001) Aberrant promoter methylation profile of bladder cancer and its relationship to clinicopathological features. Cancer Res 61:8659–8663

    CAS  PubMed  Google Scholar 

  • Matsumura T, Makino R, Mitamura K (2001) Frequent down-regulation of E-cadherin by genetic and epigenetic changes in the malignant progression of hepatocellular carcinomas. Clin Cancer Res 7:594–599

    CAS  PubMed  Google Scholar 

  • Matsuyoshi N, Hamaguchi M, Taniguchi S, Nagafuchi A, Tsukita S, Takeichi M (1992) Cadherin-mediated cell-cell adhesion is perturbed by v-src tyrosine phosphorylation in metastatic fibroblasts. J Cell Biol 118:703–714

    Article  CAS  PubMed  Google Scholar 

  • Mazaki T, Ishii Y, Fujii M, Iwai S, Ishikawa K (1996) Mutations of p53, E-cadherin, alphaand beta-catenin genes and tyrosine phosphorylation of beta-catenin in human gastric carcinomas. Int J Oncol 9:579–583

    CAS  Google Scholar 

  • Mbalaviele G, Dunstan CR, Sasaki A, Williams PJ, Mundy GR, Yoneda T (1996) E-cadherin expression in human breast cancer cells suppresses the development of osteolytic bone metastases in an experimental metastasis model. Cancer Res 56:4063–4070

    CAS  PubMed  Google Scholar 

  • Meiners S, Brinkmann V, Naundorf H, Birchmeier W (1998) Role of morphogenetic factors in metastasis of mammary carcinoma cells. Oncogene 16:9–20

    Article  CAS  PubMed  Google Scholar 

  • Melki JR, Vincent PC, Clark SJ (1999) Concurrent DNA hypermethylation of multiple genes in acute myeloid leukemia. Cancer Res 59:3730–3740

    CAS  PubMed  Google Scholar 

  • Melki JR, Vincent PC, Brown RD, Clark SJ (2000) Hypermethylation of E-cadherin in leukemia. Blood 95:3208–3213

    CAS  PubMed  Google Scholar 

  • Meng QH, Qi M, Chen DZ, Yuan RQ, Goldberg ID, Rosen EM, Auborn K, Fan SJ (2000) Suppression of breast cancer invasion and migration by indole-3-carbinol: associated with up-regulation of BRCA1 and E-cadherin/catenin complexes. J Mol Med 78:155–165

    Article  CAS  PubMed  Google Scholar 

  • Miettinen PJ, Ebner R, Lopez AR, Derynck R (1994) TGF-beta induced transdifferentiation of mammary epithelial cells to mesenchymal cells: involvement of type I receptors. J Cell Biol 127:2021–2036

    Article  CAS  PubMed  Google Scholar 

  • Mingchao, Devereux TR, Stockton P, Sun K, Sills RC, Clayton N, Portier M, Flake G (2001) Loss of E-cadherin expression in gastric intestinal metaplasia and later stage p53 altered expression in gastric carcinogenesis. Exp Toxicol Pathol 53:237–246

    Article  CAS  PubMed  Google Scholar 

  • Miyaki M, Tanaka K, Kikuchi-Yanoshita R, Muraoka M, Konishi M, Takeichi M (1995) Increased cell-substratum adhesion, and decreased gelatinase secretion and cell growth, induced by E-cadherin transfection of human colon carcinoma cells. Oncogene 11:2547–2552

    CAS  PubMed  Google Scholar 

  • Moersig W, Horn S, Hilker M, Mayer E, Oelert H (2002) Transfection of E-cadherin cDNA in human lung tumor cells reduces invasive potential of tumors. Thorac Cardiovasc Surg 50:45–48

    Article  CAS  PubMed  Google Scholar 

  • Muller N, Reinacher-Schick A, Baldus S, Van Hengel J, Berx G, Baar A, Van Roy F, Schmiegel W, Schwarte-Waldhoff I (2002) Smad4 induces the tumor suppressor E-cadherin and P-cadherin in colon carcinoma cells. Oncogene 21:6049–6058

    Article  PubMed  CAS  Google Scholar 

  • Munro SB, Turner IM, Farookhi R, Blaschuk OW, Jothy S (1995) E-cadherin and OB-cadherin mRNA levels in normal human colon and colon carcinoma. Exp Mol Pathol 62:118–122

    Article  CAS  PubMed  Google Scholar 

  • Murant SJ, Rolley N, Phillips SMA, Stower M, Maitland NJ (2000) Allelic imbalance within the E-cadherin gene is an infrequent event in prostate carcinogenesis. Gene Chromos Cancer 27:104–109

    Article  CAS  Google Scholar 

  • Muta H, Noguchi M, Kanai Y, Ochiai A, Nawata H, Hirohashi S (1996) E-cadherin gene mutations in signet ring cell carcinoma of the stomach. Jpn J Cancer Res 87:843–848

    CAS  PubMed  Google Scholar 

  • Nakayama S, Sasaki A, Mese H, Alcalde RE, Tsuji T, Matsumura T (2001) The E-cadherin gene is silenced by CpG methylation in human oral squamous cell carcinomas. Int J Cancer 93:667–673

    Article  CAS  PubMed  Google Scholar 

  • Nam JS, Ino Y, Sakamoto M, Hirohashi S (2002) Ras farnesylation inhibitor FTI-277 restores the E-cadherin/catenin cell adhesion system in human cancer cells and reduces cancer metastasis. Jpn J Cancer Res 93:1020–1028

    CAS  PubMed  Google Scholar 

  • Nass SJ, Herman JG, Gabrielson E, Iversen PW, Parl FF, Davidson NE, Graff JR (2000) Aberrant methylation of the estrogen receptor and E-cadherin 5′ CpG islands increases with malignant progression in human breast cancer. Cancer Res 60:4346–4348

    CAS  PubMed  Google Scholar 

  • Natt E, Magenis RE, Zimmer J, Mansouri A, Scherer G (1989) Regional assignment of the human loci for uvomorulin (UVO) and chymotrypsinogen B (CTRB) with the help of two overlapping deletions on the long arm of chromosome 16. Cytogenet Cell Genet 50:145–148

    Article  CAS  PubMed  Google Scholar 

  • Nawrocki-Raby B, Gilles C, Polette M, Martinella-Catusse C, Bonnet N, Puchelle E, Foidart J-M, van Roy F, Birembaut P (2003) E-cadherin mediates MMP down-regulation in highly invasive bronchial tumor cells. Am J Pathol 163:653–661

    CAS  PubMed  Google Scholar 

  • Nieman MT, Prudoff RS, Johnson KR, Wheelock MJ (1999) N-cadherin promotes motility in human breast cancer cells regardless of their E-cadherin expression. J Cell Biol 147:631–643

    Article  CAS  PubMed  Google Scholar 

  • Noë V, Willems J, Van de Kerckhove J, Van Roy F, Bruyneel E, Mareel M (1999) Inhibition of adhesion and induction of epithelial cell invasion by HAV-containing E-cadherinspecific peptides. J Cell Sci 112:127–135

    PubMed  Google Scholar 

  • Noë V, Fingleton B, Jacobs K, Crawford HC, Vermeulen S, Steelant W, Bruyneel E, Matrisian LM, Mareel M (2001) Release of an invasion promoter E-cadherin fragment by matrilysin and stromelysin-1. J Cell Sci 114:111–118

    PubMed  Google Scholar 

  • Nojima D, Nakajima K, Li LC, Franks J, Ribeiro L, Ishii N, Dahiya R (2001) CpG methylation of promoter region inactivates E-cadherin gene in renal cell carcinoma. Mol Carcinogen 32:19–27

    Article  CAS  Google Scholar 

  • Nollet F, Berx G, van Roy F (1999) The role of the E-cadherin/catenin adhesion complex in the development and progression of cancer. Mol Cell Biol Res Commun 2:77–85

    Article  CAS  PubMed  Google Scholar 

  • Oliveira C, Bordin MC, Grehan N, Huntsman D, Suriano G, Machado JC, Kiviluoto T, Aaltonen L, Jackson CE, Seruca R, Caldas C (2002) Screening E-cadherin in gastric cancer families reveals germline mutations only in hereditary diffuse gastric cancer kindred. Hum Mutat 19:510–517

    Article  CAS  PubMed  Google Scholar 

  • Padovan E, Terracciano L, Certa U, Jacobs B, Reschner A, Bolli M, Spagnoli GC, Borden EC, Heberer M (2002) Interferon stimulated gene 15 constitutively produced by melanoma cells induces E-cadherin expression on human dendritic cells. Cancer Res 62:3453–3458

    CAS  PubMed  Google Scholar 

  • Pan Y, Matsuyama H, Wang NN, Yoshihiro S, Haggarth L, Li C, Tribukait B, Ekman P, Bergerheim USR (1998) Chromosome 16q24 deletion and decreased E-cadherin expression: possible association with metastatic potential in prostate cancer. Prostate 36:31–38

    Article  CAS  PubMed  Google Scholar 

  • Papadavid E, Pignatelli M, Zakynthinos S, Krausz T, Chu AC (2001) The potential role of abnormal E-cadherin and alpha-, beta-and gamma-catenin immunoreactivity in the determination of the biological behaviour of keratoacanthoma. Br J Dermatol 145:582–589

    Article  CAS  PubMed  Google Scholar 

  • Papadavid E, Pignatelli M, Zakynthinos S, Krausz T, Chu AC (2002) Abnormal immunoreactivity of the E-cadherin/catenin (alpha-, beta-, and gamma-) complex in premalignant and malignant non-melanocytic skin tumours. J Pathol 196:154–162

    Article  CAS  PubMed  Google Scholar 

  • Paredes J, Milanezi F, Viegas L, Amendoeira I, Schmitt F (2002) P-cadherin expression is associated with high-grade ductal carcinoma in situ of the breast. Virchows Arch 440:16–21

    Article  CAS  PubMed  Google Scholar 

  • Pasqualini ME, Heyd VL, Manzo P, Eynard AR (2003) Association between E-cadherin expression by human colon, bladder and breast cancer cells and the 13-HODE:15-HETE ratio. A possible role of their metastatic potential. Prostaglandins Leukot Essent Fatty Acids 68:9–16

    Article  CAS  PubMed  Google Scholar 

  • Pece S, Gutkind JS (2002) E-cadherin and Hakai: signalling, remodeling or destruction? Nat Cell Biol 4:E72–E74

    Article  CAS  PubMed  Google Scholar 

  • Perez-Moreno MA, Locascio A, Rodrigo I, Dhondt G, Portillo F, Nieto MA, Cano A (2001) A new role for E12/E47 in the repression of E-cadherin expression and epithelialmesenchymal transitions. J Biol Chem 276:27424–27431

    Article  CAS  PubMed  Google Scholar 

  • Perl AK, Wilgenbus P, Dahl U, Semb H, Christofori G (1998) A causal role for E-cadherin in the transition from adenoma to carcinoma. Nature 392:190–193

    Article  CAS  PubMed  Google Scholar 

  • Perry I, Tselepis C, Hoyland J, Iqbal TH, Sanders DSA, Cooper BT, Jankowski JAZ (1999) Reduced cadherin/catenin complex expression in celiac disease can be reproduced in vitro by cytokine stimulation. Lab Invest 79:1489–1499

    CAS  PubMed  Google Scholar 

  • Piek E, Moustakas A, Heldin CH, Ten Dijke P (1999) TGF-β type I receptor/ALK-5 and Smad proteins mediate epithelial to mesenchymal transdifferentiation in NMuMG breast epithelial cells. J Cell Sci 112:4557–4568

    CAS  PubMed  Google Scholar 

  • Pishvaian MJ, Feltes CM, Thompson P, Bussemakers MJ, Schalken JA, Byers SW (1999) Cadherin-11 is expressed in invasive breast cancer cell lines. Cancer Res 59:947–952

    CAS  PubMed  Google Scholar 

  • Ranscht B, Dours-Zimmermann MT (1991) T-cadherin, a novel cadherin cell adhesion molecule in the nervous system lacks the conserved cytoplasmic region. Neuron 7:391–402

    Article  CAS  PubMed  Google Scholar 

  • Rashid MG, Sanda MG, Vallorosi CJ, RiosDoria J, Rubin MA, Day ML (2001) Posttranslational truncation and inactivation of human E-cadherin distinguishes prostate cancer from matched normal prostate. Cancer Res 61:489–492

    CAS  PubMed  Google Scholar 

  • Reichmann E, Schwarz H, Deiner EM, Leitner I, Eilers M, Berger J, Busslinger M, Beug H (1992) Activation of an inducible c-FosER fusion protein causes loss of epithelial polarity and triggers epithelial-fibroblastoid cell conversion. Cell 71:1103–1116

    Article  CAS  PubMed  Google Scholar 

  • Ribeiro-Filho LA, Franks J, Sasaki M, Shiina H, Li LC, Nojima D, Arap S, Carroll P, Enokida H, Nakagawa M, Yonezawa S, Dahiya R (2002) CpG hypermethylation of promoter region and inactivation of E-cadherin gene in human bladder cancer. Mol Carcinogen 34:187–198

    Article  CAS  Google Scholar 

  • Richards FM, McKee SA, Rajpar MH, Cole TRP, Evans DGR, Jankowski JA, McKeown C, Sanders DSA, Maher ER (1999) Germline E-cadherin gene (CDH1) mutations predispose to familial gastric cancer and colorectal cancer. Hum Mol Genet 8:607–610

    Article  CAS  PubMed  Google Scholar 

  • Rios-Doria J, Day KC, Kuefer R, Rashid MG, Chinnaiyan AM, Rubin MA, Day ML (2003) The role of calpain in the proteolytic cleavage of E-cadherin in prostate and mammary epithelial cells. J Biol Chem 278:1372–1379

    Article  CAS  PubMed  Google Scholar 

  • Risinger JI, Berchuck A, Kohler MF, Boyd J (1994) Mutations of the E-cadherin gene in human gynecologic cancers. Nat Genet 7:98–102

    Article  CAS  PubMed  Google Scholar 

  • Rocha AS, Soares P, Seruca R, Maximo V, Matias-Guiu X, Cameselle-Teijeiro J, Sobrinho-Simoes M (2001) Abnormalities of the E-cadherin/catenin adhesion complex in classical papillary thyroid carcinoma and in its diffuse sclerosing variant. J Pathol 194:358–366

    Article  CAS  PubMed  Google Scholar 

  • Rocha AS, Soares P, Machado JC, Maximo V, Fonseca E, Franssila K, Sobrinho-Simoes M (2002) Mucoepidermoid carcinoma of the thyroid: a tumour histotype characterised by P-cadherin neoexpression and marked abnormalities of E-cadherin/catenins complex. Virchows Arch 440:498–504

    Article  CAS  PubMed  Google Scholar 

  • Rong HJ, Boterberg T, Maubach J, Stove C, Depypere H, Van Slambrouck S, Serreyn R, De Keuketeire D, Mareel M, Bracke M (2001) 8-Prenylnaringenin, the phytoestrogen in hops and beer, upregulates the function of the E-cadherin/catenin complex in human mammary carcinoma cells. Eur J Cell Biol 80:580–585

    Article  CAS  PubMed  Google Scholar 

  • Rosivatz E, Becker I, Specht K, Fricke E, Luber B, Busch R, Hofler H, Becker KF (2002) Differential expression of the epithelial-mesenchymal transition regulators Snail, SIP1, and Twist in gastric cancer. Am J Pathol 161:1881–1891

    CAS  PubMed  Google Scholar 

  • Runswick SK, O’Hare MJ, Jones L, Streuli CH, Garrod DR (2001) Desmosomal adhesion regulates epithelial morphogenesis and cell positioning. Nat Cell Biol 3:823–830

    Article  CAS  PubMed  Google Scholar 

  • Ryniers F, Stove C, Goethals M, Brackenier L, Noë V, Bracke M, Vandekerckhove J, Mareel M, Bruyneel E (2002) Plasmin produces an E-cadherin fragment that stimulates cancer cell invasion. Biol Chem 383:159–165

    Article  CAS  PubMed  Google Scholar 

  • Saito A, Kanai Y, Maesawa C, Ochiai A, Torii A, Hirohashi S (1999) Disruption of E-cadherin-mediated cell adhesion systems in gastric cancers in young patients. Jpn J Cancer Res 90:993–999

    CAS  PubMed  Google Scholar 

  • Saito T, Katagiri A, Watanabe R, Tanikawa T, Kawasaki T, Tomita Y, Takahashi K (2000a) Expression of E-cadherin and catenins on testis tumor. Urol Int 65:140–143

    Article  CAS  PubMed  Google Scholar 

  • Saito T, Oda Y, Sakamoto A, Tamiya S, Kinukawa N, Hayashi K, Iwamoto Y, Tsuneyoshi M (2000b) Prognostic value of the preserved expression of the E-cadherin and catenin families of adhesion molecules and of beta-catenin mutations in synovial sarcoma. J Pathol 192:342–350

    Article  CAS  PubMed  Google Scholar 

  • Saito Y, Takazawa H, Uzawa K, Tanzawa H, Sato K (1998) Reduced expression of E-cadherin in oral squamous cell carcinoma: relationship with DNA methylation of 5′ CpG island. Int J Oncol 12:293–298

    CAS  PubMed  Google Scholar 

  • Salahshor S, Haixin L, Huo H, Kristensen VN, Loman N, Sjoberg-Margolin S, Borg A, Borresen-Dale AL, Vorechovsky I, Lindblom A (2001a) Low frequency of E-cadherin alterations in familial breast cancer. Breast Cancer Res 3:199–207

    Article  CAS  PubMed  Google Scholar 

  • Salahshor S, Hou H, Diep CB, Loukola A, Zhang H, Liu T, Chen J, Iselius L, Rubio C, Lothe RA, Aaltonen L, Sun XF, Lindmark G, Lindblom A (2001b) A germline E-cadherin mutation in a family with gastric and colon cancer. Int J Mol Med 8:439–443

    CAS  PubMed  Google Scholar 

  • Sanders DSA, Perry I, Hardy R, Jankowski J (2000) Aberrant P-cadherin expression is a feature of clonal expansion in the gastrointestinal tract associated with repair and neoplasia. J Pathol 190:526–530

    Article  CAS  PubMed  Google Scholar 

  • Sato H, Hasegawa T, Abe Y, Sakai H, Hirohashi S (1999) Expression of E-cadherin in bone and soft tissue sarcomas: A possible role in epithelial differentiation. Hum Pathol 30:1344–1349

    Article  CAS  PubMed  Google Scholar 

  • Sato M, Mori Y, Sakurada A, Fujimura S, Horii A (1998) The H-cadherin (CDH13) gene is inactivated in human lung cancer. Hum Genet 103:96–101

    Article  CAS  PubMed  Google Scholar 

  • Schönborn I, Zschiesche W, Behrens J, Herrenknecht K, Birchmeier W (1997) Expression of E-cadherin/catenin complexes in breast cancer: correlation with favourable prognostic factors and survival. Int J Oncol 11:1327–1334

    Google Scholar 

  • Shi Y, Sawada JI, Sui G, Affar EB, Whetstine JR, Lan F, Ogawa H, Luke MPS, Nakatani Y, Shi Y (2003) Coordinated histone modifications mediated by a CtBP co-repressor complex. Nature 422:735–738

    Article  CAS  PubMed  Google Scholar 

  • Shimamura T, Sakamoto M, Ino Y, Sato Y, Shimada K, Kosuge T, Sekihara H, Hirohashi S (2003) Dysadherin overexpression in pancreatic ductal adenocarcinoma reflects tumor aggressiveness: relationship to E-cadherin expression. J Clin Oncol 21:659–667

    Article  CAS  PubMed  Google Scholar 

  • Shimazui T, Giroldi LA, Bringuier PP, Oosterwijk E, Schalken JA (1996) Complex cadherin expression in renal cell carcinoma. Cancer Res 56:3234–3237

    CAS  PubMed  Google Scholar 

  • Shimoyama Y, Hirohashi S (1991) Cadherin intercellular adhesion molecule in hepatocellular carcinomas: loss of E-cadherin expression in an undifferentiated carcinoma. Cancer Lett 57:131–135

    Article  CAS  PubMed  Google Scholar 

  • Shinmura K, Kohno T, Takahashi M, Sasaki A, Ochiai A, Guilford P, Hunter A, Reeve AE, Sugimura H, Yamaguchi N, Yokota J (1999) Familial gastric cancer: clinicopathological characteristics, RER phenotype and germline p53 and E-cadherin mutations. Carcinogenesis 20:1127–1131

    Article  CAS  PubMed  Google Scholar 

  • Si HX, Tsao SW, Lam KY, Srivastava G, Liu Y, Wong YC, Shen ZY, Cheung ALM (2001) E-cadherin expression is commonly downregulated by CpG island hypermethylation in esophageal carcinoma cells. Cancer Lett 173:71–78

    Article  CAS  PubMed  Google Scholar 

  • Silye R, Karayiannakis AJ, Syrigos KN, Poole S, VanNoorden S, Batchelor W, Regele H, Sega W, Boesmueller H, Krausz T, Pignatelli M (1998) E-cadherin/catenin complex in benign and malignant melanocytic lesions. J Pathol 186:350–355

    Article  CAS  PubMed  Google Scholar 

  • Simonneau L, Kitagawa M, Suzuki S, Thiery JP (1995) Cadherin 11 expression marks the mesenchymal phenotype: towards new functions for cadherins? Cell Adhes Commun 3:115–130

    Article  CAS  PubMed  Google Scholar 

  • Slaton JW, Karashima T, Perrotte P, Inoue K, Kim SJ, Izawa J, Kedar D, McConkey DJ, Millikan R, Sweeney P, Yoshikawa C, Shuin T, Dinney CP (2001) Treatment with lowdose interferon-alpha restores the balance between matrix metalloproteinase-9 and E-cadherin expression in human transitional cell carcinoma of the bladder. Clin Cancer Res 7:2840–2853

    CAS  PubMed  Google Scholar 

  • Smits R, Ruiz P, DiazCano S, Luz A, JagmohanChangur S, Breukel C, Birchmeier C, Birchmeier W, Fodde R (2000) E-cadherin and adenomatous polyposis coli mutations are synergic in intestinal tumor initiation in mice. Gastroenterology 119:1045–1053

    Article  CAS  PubMed  Google Scholar 

  • Soares P, Berx G, van Roy F, Sobrinho-Simões M (1997) E-cadherin gene alterations are rare events in thyroid tumors. Int J Cancer 70:32–38

    Article  CAS  PubMed  Google Scholar 

  • Soler AP, Knudsen KA, Tecson-Miguel A, McBrearty FX, Han AC, Salazar H (1997) Expression of E-cadherin and N-cadherin in surface epithelial-stromal tumors of the ovary distinguishes mucinous from serous and endometrioid tumors. Hum Pathol 28:734–739

    Article  Google Scholar 

  • Soler AP, Knudsen KA, Salazar H, Han AC, Keshgegian AA (1999) P-cadherin expression in breast carcinoma indicates poor survival. Cancer 86:1263–1272

    Article  Google Scholar 

  • Somasiri A, Howarth A, Goswami D, Dedhar S, Roskelley CD (2001) Overexpression of the integrin-linked kinase mesenchymally transforms mammary epithelial cells. J Cell Sci 114:1125–1136

    CAS  PubMed  Google Scholar 

  • Spagnoli FM, Cicchini C, Tripodi M, Weiss MC (2000) Inhibition of MMH (Met murine hepatocyte) cell differentiation by TGF(beta) is abrogated by pre-treatment with the heritable differentiation effector FGF1. J Cell Sci 113:3639–3647

    CAS  PubMed  Google Scholar 

  • Spath GF, Weiss MC (1998) Hepatocyte nuclear factor 4 provokes expression of epithelial marker genes, acting as a morphogen in dedifferentiated hepatoma cells. J Cell Biol 140:935–946

    Article  CAS  PubMed  Google Scholar 

  • St Croix B, Sheehan C, Rak JW, Florenes VA, Slingerland JM, Kerbel RS (1998) E-cadherin-dependent growth suppression is mediated by the cyclin-dependent kinase inhibitor p27(KIP1). J Cell Biol 142:557–571

    Article  CAS  PubMed  Google Scholar 

  • St Croix BS, Kerbel RS (1997) Cell adhesion and drug resistance in cancer. Curr Opin Oncol 9:549–556

    Article  CAS  PubMed  Google Scholar 

  • Stockinger A, Eger A, Wolf J, Beug H, Foisner R (2001) E-cadherin regulates cell growth by modulating proliferation-dependent beta-catenin transcriptional activity. J Cell Biol 154:1185–1196

    Article  CAS  PubMed  Google Scholar 

  • Strumane K, van Roy F, Berx G (2003) The role of E-cadherin in epithelial differentiation and cancer progression. In: Pandalai SG (ed) Recent research development in cellular biochemistry. Transworld Research Network, Kerala, pp 33–77

    Google Scholar 

  • Sulzer MA, Leers MPG, vanNoord JA, Bollen ECM, Theunissen PHMH (1998) Reduced E-cadherin expression is associated with increased lymph node metastasis and unfavorable prognosis in non-small cell lung cancer. Amer J Respir Crit Care Med 157:1319–1323

    CAS  Google Scholar 

  • Sundfeldt K, Piontkewitz Y, Ivarsson K, Nilsson O, Hellberg P, Brannstrom M, Janson PO, Enerback S, Hedin L (1997) E-cadherin expression in human epithelial ovarian cancer and normal ovary. Int J Cancer 74:275–280

    Article  CAS  PubMed  Google Scholar 

  • Suzuki H, Komiya A, Emi M, Kuramochi H, Shiraishi T, Yatani R, Shimazaki J (1996) Three distinct commonly deleted regions of chromosome arm 16q in human primary and metastatic prostate cancers. Gene Chromos Cancer 17:225–233

    Article  CAS  Google Scholar 

  • Taddei I, Piazzini M, Bartoletti R, Dal Canto M, Sardi I (2000) Molecular alterations of E-cadherin gene: possible role in human bladder carcinogenesis. Int J Mol Med 6:201–208

    CAS  PubMed  Google Scholar 

  • Takahashi K, Suzuki K (1996) Density-dependent inhibition of growth involves prevention of EGF receptor activation by E-cadherin-mediated cell-cell adhesion. Exp Cell Res 226:214–222

    Article  CAS  PubMed  Google Scholar 

  • Takeuchi T, Liang SB, Ohtsuki Y (2002a) Downregulation of expression of a novel cadherin molecule, T-cadherin, in basal cell carcinoma of the skin. Mol Carcinogen 35:173–179

    Article  CAS  Google Scholar 

  • Takeuchi T, Liang SB, Matsuyoshi N, Zhou SX, Miyachi Y, Sonobe H, Ohtsuki Y (2002b) Loss of T-cadherin (CDH13, H-cadherin) expression in cutaneous squamous cell carcinoma. Lab Invest 82:1023–1029

    CAS  PubMed  Google Scholar 

  • Tamura G, Yin J, Wang S, Fleisher AS, Zou TT, Abraham JM, Kong DH, Smolinski KN, Wilson KT, James SP, Silverberg SG, Nishizuka S, Terashima M, Motoyama T, Meltzer SJ (2000) E-cadherin gene promoter hypermethylation in primary human gastric carcinomas. J Natl Cancer Inst 92:569–573

    Article  CAS  PubMed  Google Scholar 

  • Tamura G, Sato K, Akiyama S, Tsuchiya T, Endoh Y, Usuba O, Kimura W, Nishizuka S, Motoyama T (2001) Molecular characterization of undifferentiated-type gastric carcinoma. Lab Invest 81:593–598

    CAS  PubMed  Google Scholar 

  • Tan C, Costello P, Sanghera J, Dominguez D, Baulida J, de Herreros AG, Dedhar S (2001) Inhibition of integrin linked kinase (ILK) suppresses beta-catenin-Lef/Tcf-dependent transcription and expression of the E-cadherin repressor, Snail, in APC-/-human colon carcinoma cells. Oncogene 20:133–140

    Article  CAS  PubMed  Google Scholar 

  • Testa JR, Bellacosa A (2001) AKT plays a central role in tumorigenesis. Proc Natl Acad Sci USA 98:10983–10985

    Article  CAS  PubMed  Google Scholar 

  • Thiery JP (2002) Epithelial-mesenchymal transitions in tumour progression. Nat Rev Cancer 2:442–554

    Article  CAS  PubMed  Google Scholar 

  • Tomlinson JS, Alpaugh ML, Barsky SH (2001) An intact overexpressed E-cadherin/alpha, beta-catenin axis characterizes the lymphovascular emboli of inflammatory breast carcinoma. Cancer Res 61:5231–5241

    CAS  PubMed  Google Scholar 

  • Torban E, Goodyer PR (1998) Effects of PAX2 expression in a human fetal kidney (HEK293) cell line. Biochim Biophys Acta 1401:53–62

    Article  CAS  PubMed  Google Scholar 

  • Toyooka KO, Toyooka S, Virmani AK, Sathyanarayana UG, Euhus DM, Gilcrease M, Minna JD, Gazdar AF (2001) Loss of expression and aberrant methylation of the CDH13 (H-cadherin) gene in breast and lung carcinomas. Cancer Res 61:4556–4560

    CAS  PubMed  Google Scholar 

  • Toyooka S, Toyooka KO, Harada K, Miyajima K, Makarla P, Sathyanarayana UG, Yin J, Sato F, Shivapurkar N, Meltzer SJ, Gazdar AF (2002) Aberrant methylation of the CDH13 (H-cadherin) promoter region in colorectal cancers and adenomas. Cancer Res 62:3382–3386

    CAS  PubMed  Google Scholar 

  • Tran NL, Adams DG, Vaillancourt RR, Heimark RL (2002) Signal transduction from N-cadherin increases Bcl-2. Regulation of the phosphatidylinositol 3-kinase/Akt pathway by homophilic adhesion and actin cytoskeletal organization. J Biol Chem 277:32905–32914

    Article  CAS  PubMed  Google Scholar 

  • Tselepis C, Chidgey M, North A, Garrod D (1998) Desmosomal adhesion inhibits invasive behavior. Proc Natl Acad Sci USA 95:8064–8069

    Article  CAS  PubMed  Google Scholar 

  • Tsujii M, DuBois RN (1995) Alterations in cellular adhesion and apoptosis in epithelial cells overexpressing prostaglandin endoperoxide synthase 2. Cell 83:493–501

    Article  CAS  PubMed  Google Scholar 

  • Umbas R, Isaacs WB, Bringuier PP, Xue Y, Debruyne FMJ, Schalken JA (1997) Relation between aberrant alpha-catenin expression and loss of E-cadherin function in prostate cancer. Int J Cancer 74:374–377

    Article  CAS  PubMed  Google Scholar 

  • Vallorosi CJ, Day KC, Zhao X, Rashid MG, Rubin MA, Johnson KR, Wheelock MJ, Day ML (2000) Truncation of the beta-catenin binding domain of E-cadherin precedes epithelial apoptosis during prostate and mammary involution. J Biol Chem 275:3328–3334

    Article  CAS  PubMed  Google Scholar 

  • Van Aken E, De Wever O, Correia da Rocha AS, Mareel M (2001) Defective E-cadherin/catenin complexes in human cancer. Virchows Arch 439:725–751

    PubMed  Google Scholar 

  • Van Grunsven LA, Michiels C, Van De Putte T, Nelles L, Wuytens G, Verschueren K, Huylebroeck D (2003) Interaction between Smad-interacting protein-1 and the corepressor C-terminal binding protein is dispensable for transcriptional repression of E-cadherin. J Biol Chem 278:26135–26145

    Article  PubMed  CAS  Google Scholar 

  • Vermeulen S, Bruyneel E, van Roy F, Mareel M, Bracke M (1995) Activation of the E-cadherin/catenin complex in human MCF-7 breast cancer cells by all-trans-retinoic acid. Br J Cancer 72:1447–1453

    CAS  PubMed  Google Scholar 

  • Vizirianakis IS, Chen YQ, Kantak SS, Tsiftsoglou AS, Kramer RH (2002) Dominant-negative E-cadherin alters adhesion and reverses contact inhibition of growth in breast carcinoma cells. Int J Oncol 21:135–144

    CAS  PubMed  Google Scholar 

  • Vleminckx K, Vakaet Jr L, Mareel M, Fiers W, van Roy F (1991) Genetic manipulation of E-cadherin expression by epithelial tumor cells reveals an invasion suppressor role. Cell 66:107–119

    Article  CAS  PubMed  Google Scholar 

  • Vleminckx KL, Deman JJ, Bruyneel EA, Van den Bossche GMR, Keirsebilck AA, Mareel MM, van Roy FM (1994) Enlarged cell-associated proteoglycans abolish E-cadherin functionality in invasive tumor cells. Cancer Res 54:873–877

    CAS  PubMed  Google Scholar 

  • Vos CBJ, Cleton-Jansen A-M, Berx G, de Leeuw WJF, ter Haar NT, van Roy F, Cornelisse CJ, Peterse JL, van de Vijver MJ (1997) E-cadherin inactivation in lobular carcinoma in situ of the breast: an early event in tumorigenesis. Br J Cancer 76:1131–1133

    CAS  PubMed  Google Scholar 

  • Wang G, Huang CH, Zhao Y, Cai L, Wang Y, Xiu SJ, Jiang ZW, Yang S, Zhao T, Huang W, Gu JR (2000a) Genetic aberration in primary hepatocellular carcinoma: correlation between p53 gene mutation and loss-of-heterozygosity on chromosome 16q21–q23 and 9p21–p23. Cell Res 10:311–323

    Article  CAS  PubMed  Google Scholar 

  • Wang JZ, Krill D, Torbenson M, Wang Q, Bisceglia M, Stoner J, Thomas A, De Flavia P, Dhir R, Becich MJ (2000b) Expression of cadherins and catenins in paired tumor and non-neoplastic primary prostate cultures and corresponding prostatectomy specimens. Urol Res 28:308–315

    Article  CAS  PubMed  Google Scholar 

  • Washington K, Chiappori A, Hamilton K, Shyr Y, Blanke C, Johnson D, Sawyers J, Beauchamp D (1998) Expression of beta-catenin, alpha-catenin, and E-cadherin in Barretts esophagus and esophageal adenocarcinomas. Modern Pathol 11:805–813

    CAS  Google Scholar 

  • Wijnhoven BPL, de Both NJ, van Dekken H, Tilanus HW, Dinjens WNM (1999) E-cadherin gene mutations are rare in adenocarcinomas of the oesophagus. Br J Cancer 80:1652–1657

    Article  CAS  PubMed  Google Scholar 

  • Wu CY, Keightley SY, Leung-Hagesteijn C, Radeva G, Coppolino M, Goicoechea S, McDonald JA, Dedhar S (1998) Integrin-linked protein kinase regulates fibronectin matrix assembly, E-cadherin expression, and tumorigenicity. J Biol Chem 273:528–536

    Article  CAS  PubMed  Google Scholar 

  • Yabuta T, Shinmura K, Tani M, Yamaguchi S, Yoshimura K, Katai H, Nakajima T, Mochiki E, Tsujinaka T, Takami M, Hirose K, Yamaguchi A, Takenoshita S, Yokota J (2002) E-cadherin gene variants in gastric cancer families whose probands are diagnosed with diffuse gastric cancer. Int J Cancer 101:434–441

    Article  CAS  PubMed  Google Scholar 

  • Yang SZ, Kohno N, Kondo K, Yokoyama A, Hamada H, Hiwada K, Miyake M (1999) Adriamycin activates E-cadherin-mediated cell-cell adhesion in human breast cancer cells. Int J Oncol 15:1109–1115

    CAS  PubMed  Google Scholar 

  • Yi JY, Hur KC, Lee E, Jin YJ, Arteaga CL, Son YS (2002) TGF-beta1-mediated epithelial to mesenchymal transition is accompanied by invasion in the SiHa cell line. Eur J Cell Biol 81:457–468

    Article  CAS  PubMed  Google Scholar 

  • Yoo J, Park S, Kang CS, Kang SJ, Kim YK (2002) Expression of E-cadherin and p53 proteins in human soft tissue sarcomas. Arch Pathol Labor Med 126:33–38

    CAS  Google Scholar 

  • Yoon KA, Ku JL, Yang HK, Kim WH, Park SY, Park JG (1999) Germline mutations of E-cadherin gene in Korean familial gastric cancer patients. J Hum Genet 44:177–180

    Article  CAS  PubMed  Google Scholar 

  • Yoshiura K, Kanai Y, Ochiai A, Shimoyama Y, Sugimura T, Hirohashi S (1995) Silencing of the E-cadherin invasion-suppressor gene by CpG methylation in human carcinomas. Proc Natl Acad Sci USA 92:7416–7419

    Article  CAS  PubMed  Google Scholar 

  • Zhou RX, Skalli O (2000) Identification of cadherin-11 down-regulation as a common response of astrocytoma cells to transforming growth factor-alpha. Differentiation 66:165–172

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department for Molecular Biomedical Research, Ghent University and Flanders Interuniversity Institute for Biotechnology (V.I.B), Technologiepark 927, 9052, Zwijnaarde, Belgium

    K. Strumane, G. Berx & F. Van Roy

Authors
  1. K. Strumane
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. G. Berx
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. F. Van Roy
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to F. Van Roy .

Editor information

Editors and Affiliations

  1. Nikolaus-Fiebiger-Zentrum für Molekulare Medizin, Universität Erlangen-Nürnberg, Glückstrasse 6, 91054, Erlangen, Germany

    Jürgen Behrens

  2. Department of Molecular & Cellular Physiology Beckman Center B121, Stanford University School of Medicine, Stanford, CA, 94305-5345, USA

    W. James Nelson Ph.D.

Rights and permissions

Reprints and permissions

Copyright information

© 2004 Springer-Verlag

About this chapter

Cite this chapter

Strumane, K., Berx, G., Van Roy, F. (2004). Cadherins in Cancer. In: Behrens, J., Nelson, W.J. (eds) Cell Adhesion. Handbook of Experimental Pharmacology, vol 165. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-540-68170-0_4

Download citation

  • DOI: https://doi.org/10.1007/978-3-540-68170-0_4

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-20941-6

  • Online ISBN: 978-3-540-68170-0

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation